ABBV Mar 2025 105.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:40PM EDT. Market open.
| Previous close | 0.9000 |
| Open | 0.9000 |
| Bid | 0.0000 |
| Ask | 2.7900 |
| Strike | 105.00 |
| Expiry date | 2025-03-21 |
| Day's range | 0.9000 - 0.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Simply Wall St.Investors in AbbVie (NYSE:ABBV) have seen impressive returns of 235% over the past five years
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...
Investor's Business DailyEli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.
PR NewswireAvailable Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the national availability of JUVÉDERM® VOLUMA® XC for temple hollowing. Following its U.S. FDA approval in March 2024, JUVÉDERM® VOLUMA® XC is the first and only hyaluronic acid (HA) filler approved to treat moderate to severe temple hollowing in adults over 21.1,2 The JUVÉDERM® Collection of Fillers is the number one chosen HA dermal filler brand by patients and providers, and now offers the largest range of treatment indications to
© 2024 Yahoo. All rights reserved.